Prof Katharine Barnard-Kelly PhD, is a Visiting Professor and internationally renowned expert who specializes in the psychosocial impact and management of illness and long-term conditions. She led the only team ever to be awarded FDA MDDT qualification for a patient-reported outcome measure in diabetes (INSPIRE). Katharine Chairs a global team of experts writing a consensus statement on the standardization of patient-reported outcomes. This will provide a blueprint for how PROs are understood and assessed in the context of mental health safety by regulatory bodies, government research funding bodies and other key stakeholder groups worldwide. She Chairs the FDA RESCUE Global Collaborative Community to reduce incidents of self-injury and suicide in diabetes. Katharine developed the underpinning theoretical model behind Spotlight-AQ; a concrete exemplar of biopsychosocial healthcare delivery within the constraints of existing healthcare systems and structures. She is the Chief Science Officer and founder. She has extensive experience in developing the evidence base and theory behind psychological interventions, in clinical trials design, management, analysis, reporting, dissemination and exploitation of project outcomes. As PI or co-Investigator on several university, industry, NIHR and NIH-funded grants, her research portfolio spans psychosocial aspects of diabetes management, health technology assessment, translational medicine and impact of technologies on the lives of people with diabetes; she has published over 250 scientific articles in high-impact journals. Katharine’s goal is to minimize the burden of diabetes for people living with it and to reduce the burden on healthcare professionals providing crucial support.
Dr. Marrero PhD, is the former Director of the Center for Health Disparities Research at the University of Arizona School of Public Health, is a distinguished research expert in the field of clinical trials in diabetes and translation research which moves scientific advances into the public health sector. His work focuses on strategies for promoting diabetes prevention, improving diabetes care practices used by primary care providers, and the use of technology to facilitate care and education. He has also conducted research on medication adherence, community health programs, and translational medicine. He served as the Director of the Diabetes Translational Research Center at Indiana University School of Medicine for 22 years where he was the J.O. Ritchey Endowed Chair in Endocrinology.
Dr. Marrero has published extensively, with over 400 articles, and has presented at numerous national and international conferences. He was twice awarded the Allene Van Son Distinguished Service Award for Diabetes Patient Education Tools by the American Association of Diabetes Educators, served as an associate editor for Diabetes Care (1997-2002). He was selected as the Outstanding Educator in Diabetes in 2008 by the American Diabetes Association and served as the national president for health care and education of the ADA in 2015. In 2021 he received the Richard R. Rubin award by the American Diabetes Association. IN 2016 he was Selected as one of the top 50 graduate and post-doctoral alumni from the 50-year anniversary of UCI, recognized for outstanding professional achievements from his alma Mater, the University of California, Irvine
Richard Holt MA MB BChir PhD FRCP FHEA trained at the University of Cambridge and the London Hospital Medical College. He is Professor in Diabetes and Endocrinology at the University of Southampton and an Honorary Consultant Physician in Diabetes and Endocrinology at the University Hospital Southampton NHS Foundation Trust.
Professor Holt’s current research interests are broadly focussed around clinical diabetes but specifically encompass studies of the relationship between mental health and diabetes. His clinical responsibilities include the diabetes and pregnancy clinic, young adult diabetes clinic and the cystic fibrosis related diabetes service.
Professor Holt was the Editor-in-Chief of Diabetic Medicine (2016-2020) and is a past-Chair of the Council of Health Care Professionals of Diabetes UK. Professor Holt was a member of the 2008 NICE diabetes and pregnancy guideline development group and the NICE Type 2 diabetes: preventing the progression from pre-diabetes programme development group. Professor Holt is the Editor-in-Chief of the 6th edition of the Textbook of Diabetes. Professor Holt is the Chair of the EASD Committee for Clinical Affairs and was the EASD co-chair of the EASD-ADA consensus report of the management of type 1 diabetes in adults.
Marisa Hilliard PhD is an Associate Professor of Pediatrics at Baylor College of Medicine and Texas Children’s Hospital. She directs the Resilience and Diabetes (RAD) Behavioral Research Lab, which primarily focuses on the application of positive psychology and the science of health behavior change to improve psychosocial, behavioral, and health outcomes of youth and young adults with type 1 diabetes and their families. Marisa is currently the Chair of the Behavioral Medicine and Psychology Interest Group of the American Diabetes Association.
Korey Hood, PhD is personally and professionally committed to improving the lives of people with diabetes. As Professor and Staff Psychologist at Stanford University School of Medicine, Dr. Hood runs a behavioral science laboratory aimed at optimizing health and quality of life outcomes. A recipient of federal and foundation grants and author of over 200 scientific articles, Dr. Hood works to put behavioral science at the forefront of person-centered diabetes care. Dr. Hood has type 1 diabetes himself and works across advocacy and service settings to promote awareness of diabetes treatments, the psychological impact, and emerging technologies. Dr. Hood is a compassionate behavioral scientist with a keen understanding of the intersection between diabetes and behavioral health.
James R. Gavin III, MD, PhD is clinical professor of medicine at Emory University School of Medicine. He serves as Chief Medical Officer of Healing Our Village, Inc. and is the Senior Consultant for Chronic Diseases for the Centers for Health Promotion, LLC. in Coral Springs, FL. He is a past president of the Morehouse School of Medicine and a past president of the American Diabetes Association (ADA). He is a member of the National Academy of Medicine, the American Society of Clinical Investigation, and the American Association of Physicians. He is Chairman Emeritus of the National Diabetes Education Program. He is national program director emeritus of the Harold Amos Medical Faculty Development Program of the Robert Wood Johnson Foundation, and Chairman Emeritus of the Board for The Partnership for a Healthier America. He has published over 250 articles and three books. He received the Emory Medal for Distinguished Achievement and the Distinguished Alumni Award from Duke University School of Medicine. He was named a Living Legend in Diabetes by AADE in 2009, received the Public Policy Leadership Award from the ADA in 2010 and in 2015, he received a Lifetime Achievement Award for Diabetes Research from ADA. He received the Laureate Mentor of the Year Award from the Endocrine Society in 2022, and the Award for Outstanding Achievement for Promoting Diversity from the American Society of Hematology in 2022. He received a B.S. from Livingstone College, earned his PhD from Emory University and his MD degree from Duke University School of Medicine.
